Pangaea knows what keeps you up at night.

Our experience in the Canadian pharma marketplace runs deep, so you can rest easy.

Pricing Pressures

Canadian Payers want the lowest price — without compromising therapeutic effectiveness. Some of the important trends are:

  • CADTH reform

  • Provinces negotiating on listing agreements. 

  • Pan Canadian Listing negotiations

  • Private Payers/Retailers adopting mandatory substitution

  • Generic pricing reform

Who takes the money out?

Pangaea can help. Our expertise in Strategic Insights & Resourcing expertise is here to help.

  • Strategic/Brand Planning Facilitation

  • Critical Paths

  • Environmental Reviews

  • Topics & Trends™

Portfolio Maximization

Managing products in your portfolio from launch to loss of exclusivity is an evolving science. Two key challenges are:

  • The need to take full advantage of product pipeline.

  • HCP's that influence product selection in channels vary from province to province. 

Pangaea has over 20 years of experience assisting Canadian pharma companies sustain growth and profitability by optimizing product lifecycles.

  • Channel Optimization

  • Launch & LOE Critical Paths 

  • Launch Excellence benchmarking

  • Environmental Reviews

  • Topics & Trends™

  • Strategic/ Brand Planning Facilitation

Commercial Compliance Conundrum

The US Sunshine Act has changed the landscape of corporate governance. When corporate policy spills into Canada, it can limit the ability to compete in this marketplace. Emerging trends include:

  • Global and industry regulatory bodies’ restricting promotional practices

  • The need to manage interconnected working relationships within your organization to meet the needs of all stakeholders

Pangaea’s experts can evaluate how corporate governance aligns with Canadian regulations and industry standards:

  • Benchmarking corporate global codes, Rx&D codes & common practices in Canada

We have been working with Pangaea for a number of years in the area of trade relations. They have proven to be invaluable when it comes to guiding us through our dealings with our key trade customers.

— Michael J. Tremblay, President Astellas Pharma Canada, Inc.

More testimonials